Author

Mariajose Franco

National Cancer InstituteORCID 0000-0002-9512-4086Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

André NussenzweigiD· 1 shared Andy D. TraniD· 1 shared Catherine Nicole Domingo· 1 shared Desiree TilloiD· 1 shared Elphège Pierre NoraiD· 1 shared Eros Lazzerini DenchiiD· 1 shared Gianluca PegoraroiD· 1 shared María Vega-SendinoiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperDevelopmental Biology

André NussenzweigORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CTCF is a Barrier for Totipotent-like Reprogramming

Teresa Olbrich, María Vega-Sendino, Desiree Tillo, Wei Wu, Nicholas Zolnerowich, Andy D. Tran, Catherine Nicole Domingo, Mariajose Franco, Marta Markiewicz-Potoczny, Gianluca Pegoraro, Peter C FitzGerald, Michael J. Kruhlak, Eros Lazzerini Denchi, Elphège Pierre Nora, André Nussenzweig, Sergio Ruiz

This study identifies CTCF as a barrier to 2C-like reprogramming in ESCs, showing its role in maintaining chromatin structure and that its depletion promotes totipotent-like state conversion.

bioRxiv · Dec 20, 2020 · PreprintDevelopmental Biology